作者
Georgios Schoretsanitis, John M Kane, Christoph U Correll, Stephen R Marder, Leslie Citrome, John W Newcomer, Delbert G Robinson, Donald C Goff, Deanna L Kelly, Oliver Freudenreich, Daria Piacentino, Michael Paulzen, Andreas Conca, Gerald Zernig, Ekkehard Haen, Pierre Baumann, Christoph Hiemke, Gerhard Gründer
发表日期
2020/5/19
期刊
The Journal of clinical psychiatry
卷号
81
期号
3
页码范围
3649
出版商
Physicians Postgraduate Press, Inc.
简介
Objective: The quantification of antipsychotic levels in blood, also known as therapeutic drug monitoring (TDM), is a potentially useful tool of modern personalized therapy that can be applied to augment antipsychotic use and dosing decisions. The application of TDM for antipsychotics can be helpful in numerous challenging clinical scenarios, such as lack of therapeutic response, relapse, or adverse drug reactions (ADRs) related to antipsychotic treatment. The benefits of TDM may be particularly evident in the treatment of highly vulnerable patient subgroups, such as children, adolescents, pregnant women, and the elderly. The main aim of this article is to aid clinicians who routinely prescribe antipsychotics to successfully apply TDM in routine clinical practice in order to help optimize the efficacy and safety of those antipsychotics.
Participants: Participants were clinicians and researchers, members of the American …
引用总数
20202021202220232024732223113